Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 331, Issue 1, pp 27–39 | Cite as

Direct labelling of myocardial β1-adrenoceptors

Comparison of binding affinity of 3H-(−)-bisoprolol with its blocking potency
  • Alberto J. Kaumann
  • Horst Lemoine


A radioligand that selectively labels β1-adrenoceptors, 3H-(−)-bisoprolol (3H-BIS), is introduced. The binding properties of 3H-BIS to membrane particles of kitten heart are compared with the blocking properties of (−)-bisoprolol against stimulant effects of (−)-adrenaline and (−)-noradrenaline in heart preparations of kitten and guinea pig.

  1. 1.

    On kitten heart tissues (-)-bisoprolol antagonized the positive chronotropic and inotropic effects of catecholamines competitively. The effects of (-)-adrenaline were antagonized considerably less by (-)-bisoprolol than the corresponding effects of (-)-noradrenaline on sinoatrial pacemakers. The antagonism was nearly the same against both (-)-adrenaline and (-)-noradrenaline in left atria and papillary muscles. The data were analyzed with a model for 2-receptor subtypes by non-linear regression. Equilibrium dissociation constants KB (mol/l; -log KB=pKB) for a high-affinity β1-adrenoceptor of 8.8 and for a low-affinity β2-adrenoceptor of 7.0 were estimated in the three classes of tissues. In kitten sinoatrial pacemaker β1-adrenoceptors contribute 76% to the stimulus induced by (-)-adrenaline and 97% to the stimulus induced by (-)-noradrenaline. In ventricle and left atrium β1-adrenoceptors contribute 97∓99% and 100% to the stimulus caused by (-)-adrenaline and (-)-noradrenaline, respectively.

  2. 2.

    Both 3H-BIS and unlabelled (-)-bisoprolol caused competitive blockade of the positive chronotropic effects of (-)-noradrenaline in guinea-pig right atria. pKB-values of 8.7 were estimated for both unlabelled and tritiated (-)-bisoprolol. The positive chronotropic effects of (-)-adrenaline were antagonized considerably less by (-)-bisoprolol than those of (-)-noradrenaline in guinea-pig atria.

    In the presence of low concentrations of β2-selective ICI 118,551, which did not antagonize β1 adrenoceptor mediated effects, (−)bisoprolol antagonized positive chronotropic effects of (−)-adrenaline to the same extent as those of (−)-noradrenaline. The results are consistent with the concept of a significant role of sinoatrial β2-adrenoceptors of guinea pig for the effects of (−)-adrenaline but not for those of (−)-noradrenaline.

  3. 3.

    3H-BIS associated and dissociated quickly with and from ventricular β1-adrenoceptors. A koff of 1.0 min-1 was estimated. An equilibrium dissociation constant pKL*of 8.2 for 3H-BIS was estimated from saturation binding. The binding competition of the optical isomers of bupranolol with 3H-BIS revealed a degree of stereo-selectivity expected for β1-adrenoceptors.

  4. 4.

    (-)-Bisoprolol competed with high affinity and low affinity, respectively, for β1- and β2-adrenoceptors of both ventricular and atrial membranes labelled with 3H-(-)-bupranolol bupranolol or 3H-(-)-propranolol. The difference in affinity of (-)-bisoprolol of 1.7±0.3 log units between β1- and β2-adrenoceptors agrees with the selectivity for β1-adrenoceptors found in intact heart tissues.

  5. 5.

    (-)-Noradrenaline and (-)-adrenaline competed with low affinity with 3H-BIS for ventricular β1-adrenoceptors. An approximately 100-fold difference between high KL-values of these catecholamines and low inotropic EC50-values is consistent with a large β1-adrenoceptor reserve.

  6. 6.

    The binding affinity for β1-adrenoceptors of both 3H-BIS and (-)-bisoprolol is 3∓8 times lower on membrane particles than on intact tissues, as also confirmed with the blockade of catecholamine-induced stimulation of the adenylate cyclase. By contrast, the affinities of (-)-propranolol and (-)-bupranolol are similar in intact tissues and on membrane particles. The low affinity of (-)-bisoprolol in membranes may be caused by a lesion of accessory recognition sites of the β1-adrenoceptors due to the procedure of membrane preparation. However, the lesion of these hypothetical accessory binding sites would not lower the affinity for (-)-propranolol and (-)-bupranolol.


Key words

Heart 3H-(−)-Bisoprolol Catecholamines β1-Adrenoceptors Binding and blockade 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58Google Scholar
  2. Bilski A, Halliday SE, Fitzgerald JD, Wale JL (1983) The pharmacology of a β 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol 5:430–437Google Scholar
  3. Birnbaumer L, Duran JM, Nakahara T, Kaumann AJ (1977) Adenylyl cyclases: stimulation by hormones and regulation by nucleotides. In: Jaimeson GA, Robinson DM (eds) Mammalian cell membranes, vol 5. Responses of plasma membranes. Butterorths. London Boston pp 105–150Google Scholar
  4. Blinks JR (1965) convenient apparatus for recording contractions of isolated muscle. J Appl Physiol 20:755–757Google Scholar
  5. Carlsson E, Åblad B, Brandstrom A, Carlsson B (1972) Differentiated blockade of the chronotropic effects of various adrenergic stimuli in the cat heart. Life Sci 11:953–958Google Scholar
  6. Chènieux-Guicheney P, Dausse JP, Meyer P, Schmitt H (1978) Inhibition of (3H)-dihydroalprenolol binding to rat cardiac membranes by various β-blocking agents. Br J Pharmacol 63:177–182Google Scholar
  7. Cruickshank JM (1980) The clinical importance of cardioselectivity and lipophilicity in beta blockers. Am Heart J 100:160–178Google Scholar
  8. De Lean A, Hancock AA, Lefkowitz RJ (1982) Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol 21:5–16Google Scholar
  9. Dickinson K, Richardson A, Nahorski SR (1980) Homogeneity of beta2-adrenoceptors on rat erythrocytes and reticulocytes. A comparison with heterogeneous rat lung beta-adrenoceptors. Molec Pharmacol 19:194–204Google Scholar
  10. Dixon WJ, Brown MB (eds) (1979) Biomedical computer programs, P series. University of California Press, Berkeley Los Angeles LondonGoogle Scholar
  11. Ehle B, Lemoine H, Kaumann AJ (1985) Improved evaluation of binding of ligands to membranes containing several receptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 331:52–59Google Scholar
  12. Gille E, Lemoine H, Ehle B, Kaumann AJ (1985) The affinity of (−)-propranolol for β 1- and β 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (−)-noradrenaline and (−)-adrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 331: 60–70Google Scholar
  13. Hancock AA, De Lean AL, Lefkowitz RJ (1979) Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique. Mol Pharmacol 16:1–9Google Scholar
  14. Hellenbrecht D, Lemmer B, Wiethold G, Grobecker H (1973) Measurements of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of non-specific membrane affinity of nine β-adrenergic blocking agents. Naunyn-Schmiedeberg's Arch Pharmacol 277:211–226Google Scholar
  15. Kaumann AJ (1970) Adrenergic receptors in heart muscle: Relations among factors influencing the sensitivity of the cat papillary muscle to catecholamines. J Pharmacol Exp Ther 173:383–398Google Scholar
  16. Kaumann AJ (1972) Potentiation of the effects of isoprenaline and noradrenaline by hydrocortisone in cat heart muscle. Naunyn-Schmiedeberg's Arch Pharmacol 273:134–153Google Scholar
  17. Kaumann AJ (1978) On spare β-adrenoceptors for inotropic effects of catecholamines in kitten ventricle. Naunyn-Schmiedeberg's Arch Pharmacol 305:97–102Google Scholar
  18. Kaumann AJ (1982) Cultured heart cells as a model for β-adrenoceptors in a heart pacemaker. Chronotropic spare β-adrenoceptors and spare adenylyl cyclase for (−)-isoprenaline but not for (−)-dichloroisoprenaline in rat cardiocytes. Naunyn-Schmiedeberg's Arch Pharmacol 320:119–129Google Scholar
  19. Kaumann AJ, Birnbaumer L (1974) Characteristics of the adrenergic receptor coupled to myocardial adenylyl cyclase. Stereospecifity and determination of apparent affinity constants for beta blockers. J Biol Chem 249:7874–7885Google Scholar
  20. Kaumann AJ, Lemoine H (1983) Large discrepancies between membrane binding and blocking affinities in tissues for antagonists that select β-adrenoceptor subtypes but not for nonselective antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 324: R 66Google Scholar
  21. Kaumann AJ, Marano M (1982) On equilibrium constants for complexes of drug-receptor subtypes. Selective and nonselective interactions of partial agonists with two plausible β-adrenoceptor subtypes mediating positive chronotropic effects of (−)-isoprenaline in kitten atria. Naunyn-Schmiedeberg's Arch Pharmacol 318:192–201Google Scholar
  22. Kaumann AJ, McInerny TK, Gilmour DP, Blinks JR (1980) Comparative assessment of β-adrenoceptor blocking agents as simple competitive antagonists in isolated heart muscle: Similarity of inotropic and chronotropic blocking potencies against isoproterenol. Naunyn-Schmiedeberg's Arch Pharmacol 311:219–236Google Scholar
  23. Kaumann AJ, Lemoine H, Morris TH, Schwederski U (1982) An initial characterization of human heart β-adrenoceptors and their mediation of the positive inotropic effects of catecholamines. Naunyn-Schmiedeberg's Arch Pharmacol 319: 216–221Google Scholar
  24. Kaumann AJ, Morris TH, Bojar H (1983) On the functional role of heterogeneous binding sites. Heart β-adrenoceptors. J Receptor Res 3:61–70Google Scholar
  25. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597–598Google Scholar
  26. Lefkowitz RJ, Stadel JM, Caron MG (1983) Adenylate cyclase-coupled beta-adrenergic receptors: Structure and mechanisms of activation and desensitization. Ann Rev Biochem 52, 159–186Google Scholar
  27. Lemoine H, Kaumann AJ (1982) A novel analysis of concentration-dependence of partial agonism. Ring-demethylation of bupranolol results in a high affinity partial agonist (K 105) for myocardial and tracheal β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 320:130–144Google Scholar
  28. Lemoine H, Kaumann AJ (1983) A model for the interaction of competitive antagonists with two receptor-subtypes characterized by a Schild-plot with apparent slope unity. Agonist-dependent enantiomeric affinity ratios for bupranolol in tracheae but not in right atria of guinea pigs. Naunyn-Schmiedeberg's Arch Pharmacol 322:111–120Google Scholar
  29. Lemoine H, Ehle B, Kaumann AJ (1985) Direct labelling of β 1-adrenoceptors. Comparison of binding potency of 3H-ICI 118,551 and blocking potency of ICI 118,551. Naunyn-Schmiedeberg's Arch Pharmacol 331:40–51Google Scholar
  30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193:265–275Google Scholar
  31. Manalan AS, Bosch HR, Watanabe AM (1981) Characterization of (3H)-(±)-carazolol binding to β-adrenergic receptors. Application to study of β-adrenergic receptor subtypres in canine ventricular myocardium and lung. Circulation Res 49:326–336Google Scholar
  32. Minneman KP, Hegstrand LR, Molinoff PB (1979) Simultancous determination of beta-1 and beta-2 adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol 16:34–46Google Scholar
  33. Minneman KP, Pittman RN, Molinoff PB (1981) β-Adrenergic receptor subtypes: Properties, distribution, and regulation. Ann Rev Neurosci 4:419–461Google Scholar
  34. Morris TH, Kaumann AJ (1979) Characterization of 3H-(±)-carazolol binding to myocardial β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 308:R 33Google Scholar
  35. Morris TH, Kaumann AJ (1984) Different steric characteristics of β 1- and β 2-adrenoceptors. Naunyn Schmiedeberg's Arch Pharmacol 327:176–179Google Scholar
  36. Morris TH, Sandrock K, Kaumann AJ (1981) 3H-(−)-Bupranolol, a new β-adrenoceptor radioligand: Characterization of its binding to kitten heart β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 317:19–25Google Scholar
  37. Moustafa E, Giachetti A, Downey HF, Bashour FA (1978) Binding of (3H)-dihydroalprenolol to beta-adrenoceptors of cells isolated from adult rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 303:107–109Google Scholar
  38. Porzig H, Becker C, Reuter H (1982) Competitive and non-competitive interactions between specific ligands and beta-adrenoceptors in living cardiac cells. Naunyn-Schmiedeberg's Arch Pharmacol 321:89–99Google Scholar
  39. Rugg EL, Barnett DB, Nahorski SR (1978) Coexistence of beta1 and beta2 adrenoceptors in mammalian lung: evidence from direct binding studies. Mol Pharmacol 14:996–1005Google Scholar
  40. Salomon Y, Londos C, Rodbell M (1974) A highly sensitive adenylate cyclase assay. Anal Biochem 58:541–548Google Scholar
  41. Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672Google Scholar
  42. Trendelenburg U (1968) The effect of cocaine on the pacemaker of isolated guinea-pig atria. J Pharmacol Exp Ther 161:222–231Google Scholar
  43. Wächter W, Münch U, Lemoine H, Kaumann AJ (1980) Evidence that (+)-bupranolol interacts directly with myocardial β-adrenoceptors: Control of optical purity with differential thermal analysis. Naunyn-Schmiedeberg's Arch Pharmacol 313:1–8Google Scholar
  44. Walter M, Lemoine H, Kaumann AJ (1984) Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of β-adrenoceptor subtypes in the dissociation between blockade and stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 327:159–175Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • Alberto J. Kaumann
    • 1
  • Horst Lemoine
    • 1
  1. 1.Lehrstuhl für Klinische PhysiologiePhysiologisches Institut der Universität DüsseldorfDüsseldorfFederal Republic of Germany

Personalised recommendations